Outcome of patients with synchronous metastatic renal cell carcinoma treated with nivolumab and ipilimumab and the primary tumour in place

被引：0
|
作者：
Jurascheck, L. [1 ]
Van de Putte, Fransen E. [2 ]
Van den Brink, L. [3 ]
Van der Mijn, J. C. [4 ]
Wilgenhof, S. [4 ]
Van Thienen, J. V. [4 ]
Haanen, J. B. A. G. [4 ]
Boleti, E. [5 ]
Powles, T. [6 ]
Zondervan, P. J. [3 ]
Graafland, N. M. [2 ]
Bex, A. [1 ]
机构：
[1] Royal Free London NHS Fdn Trust, Dept Urol, London, England
[2] Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands
[3] Amsterdam UMC, Dept Urol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Oncol, Amsterdam, Netherlands
[5] Royal Free NHS Fdn Trust, Dept Oncol, London, England
[6] Barts Canc Ctr, Dept Oncol, London, England
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0838
引用
收藏
页码：S1859 / S1860
页数：2
相关论文
共 50 条
  • [21] Predictive factors of nivolumab plus ipilimumab treatment efficacy in metastatic renal cell carcinoma patients
    Ohba, Kojiro
    Nakanishi, Hiromi
    Kawada, Ken
    Nakamura, Yuichiro
    Mitsunari, Kensuke
    Matsuo, Tomohiro
    Mochizuki, Yasushi
    Imamura, Ryoichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (07) : 827 - 832
  • [22] Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma
    Kobari, Yuki
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Kondo, Tsunenori
    Ishida, Hideki
    Tanabe, Kazunari
    Takagi, Toshio
    IN VIVO, 2021, 35 (06): : 3585 - 3589
  • [23] Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab.
    Dzimitrowicz, Hannah Elizabeth
    Schwartz, Fides
    Infield, Jordan
    Zhang, Dylan
    Ho, Ethan
    Wu, Yuan
    Gupta, Rajan T.
    Harrison, Michael Roger
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16517 - E16517
  • [24] Association between on-treatment eosinophil dynamics and outcomes in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab.
    Chen, Yu-Wei
    Tucker, Matthew D.
    Yasin, Hesham
    Ancell, Kristin Kathleen
    Davis, Nancy B.
    Haake, Scott Mattox
    Kaiser, Elizabeth
    McAlister, Renee
    Rathmell, Wendy Kimryn
    Schaffer, Kerry
    Wallace, Deborah
    Beckermann, Katy
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [25] Real-world outcomes in patients with metastatic renal cell carcinoma treated with first-line nivolumab plus ipilimumab
    Doshi, Gurjyot K.
    Robert, Nicholas J.
    Chen, Liwei
    Chan, Philip K.
    Del Tejo, Viviana
    Stwalley, Brian
    Huo, Stephen
    Geynisman, Daniel M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [26] Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab
    Ornstein, Moshe C.
    George, Laeth
    Wei, Wei
    Diaz-Montero, C. Marcela
    Rayman, Pat
    Martin, Allison
    Basu, Arnab
    Beckermann, Kathryn E.
    Nizam, Amanda
    Wee, Christopher E.
    Gilligan, Timothy D.
    Gupta, Shilpa
    Rini, Brian I.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [27] Association of lung immune prognostic index with survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
    Yamashita, Shimpei
    Hamamoto, Shuzo
    Furukawa, Junya
    Fujita, Kazutoshi
    Takahashi, Masayuki
    Miyake, Makito
    Ito, Noriyuki
    Iwamoto, Hideto
    Kohjimoto, Yasuo
    Hara, Isao
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (06) : 722 - 729
  • [28] Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial
    Courcier, J.
    Dalban, C.
    Laguerre, B.
    Ladoire, S.
    Barthelemy, P.
    Oudard, S.
    Joly, F.
    Mescam, G. Gravis
    Chevreau, C. M.
    Geoffrois, L.
    Deluche, E.
    Rolland, F.
    Topart, D.
    Culine, S.
    Negrier, S.
    Mahammedi, H.
    Tantot, F.
    Escudier, B.
    Flippot, R.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S560 - S560
  • [29] Ipilimumab and Nivolumab induced ventricular tachycardia in a patient with metastatic renal cell carcinoma
    Savarapu, Pramod
    Abdelazeem, Basel
    Isa, Sakiru
    Kesari, Kavitha
    Kunadi, Arvind
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2021, 11 (06): : 874 - 876
  • [30] Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma
    Segawa, Takuya
    Motoshima, Takanobu
    Yatsuda, Junji
    Kurahashi, Ryoma
    Fukushima, Yumi
    Murakami, Yoji
    Yamaguchi, Takahiro
    Sugiyama, Yutaka
    Yoshida, Ryoji
    Nakayama, Hideki
    Kamba, Tomomi
    IJU CASE REPORTS, 2023, 6 (02) : 147 - 149
12345